XS233225070 analysis
Key facts
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.